Epidermal insulin resistance as a therapeutic target in acanthosis nigricans?

Malisiewicz, Bartosz; Boehncke, Sandra; Lang, Victoria; Boehncke, Wolf-Henning; Buerger, Claudia

Malisiewicz, Bartosz; Boehncke, Sandra; Lang, Victoria; Boehncke, Wolf-Henning; Buerger, Claudia.

Affiliation

Malisiewicz B; Department of Dermatology, University Hospital, Theodor-Stern-Kai 7, DE-60590 Frankfurt/Main, Germany.

Acta Derm Venereol ; 94(5): 607-8, 2014 Sep.

Article in En | MEDLINE | ID: mdl-24514457

Subject(s)

Acanthosis Nigricans/drug therapy; Glucagon-Like Peptide 1/analogs & derivatives; Hypoglycemic Agents/therapeutic use; Acanthosis Nigricans/complications; Adult; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Epidermis/physiology; Female; Glucagon-Like Peptide 1/therapeutic use; Humans; Insulin Resistance/physiology; Liraglutide

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide 1 / Acanthosis Nigricans / Hypoglycemic Agents Limits: Adult / Female / Humans Language: En Journal: Acta Derm Venereol Year: 2014 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google